Twój koszyk jest obecnie pusty!
Study on the Colonization of Beneficial Microorganisms from EkoSynbiotyk in the Digestive Tract.
A detailed report has been compiled on the survivability of microorganisms contained in EkoSynbiotyk (a formulation of 11 live, active, and non-modified bacterial strains, combined with probiotics and prebiotics) within the human digestive tract. The report also evaluates its antimicrobial activity and its effectiveness against undesirable bacterial strains.
The study, conducted at the renowned Institute of Microorganism Technology, unequivocally confirmed that microorganisms in EkoSynbiotyk demonstrate approximately 90% survivability throughout the entire digestive tract and successfully colonize it.
Additionally, the antimicrobial activity of EkoSynbiotyk against a broad spectrum of undesirable and pathogenic strains has been rated very highly.


Key Findings from the Study
Based on the conducted research and observations of the changes in microorganism populations under simulated in vitro conditions that replicate the human digestive process, the following conclusions were drawn:
The probiotic microorganisms in EkoSynbiotyk exhibit high survivability at every stage of digestion.
Under digestion-simulating conditions, these microorganisms demonstrate a strong potential to colonize the small intestine, while maintaining the composition of the consortium for at least 72 hours post-administration.
The formulation enables significant colonization of the large intestine by adapted lactic acid fermentation bacterial strains introduced through EkoSynbiotyk.
EkoSynbiotyk exhibits high antimicrobial activity against pathogenic microorganisms. This activity is dynamic, leading to the rapid elimination of analyzed pathogens.
Explore the Research on EkoSynbiotyk
Laboratory studies confirmed that the microorganisms in EkoSynbiotyk maintain approximately 90% survivability throughout the entire digestive tract and effectively colonize it.